"Abattis(@Abattis) (#CSE: $ATT // #OTC: $ATTBF) Unveils "Comfort", Its Proprietary New Chronic Pain and Inflammation Product to Start Shipping November 2018 [https://t.co/HyiJtDKqzL]#POTstocks #investing #stocks #stockmarket #trading #investors #news#investments #marijuana"Read full news